Journey Medical Corp. DERM
NASDAQ · United States · Health Technology
$6.66-0.06 (-0.89%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.01 | -0.02 | +55.6% | $18.51M | +0.8% | +5.2%$6.32→$6.65 |
| Q1 2026 | 2026-05-13 | -0.08 | -0.07 | -14.3% | — | — | +26.7%$5.01→$6.35 |
| Q4 2025 | 2026-03-25 | -0.04 | -0.06 | +33.3% | — | — | -30.8%$6.91→$4.78 |
| Q3 2025 | 2025-11-12 | -0.09 | -0.08 | -12.5% | — | — | -15.0%$9.05→$7.69 |
| Q2 2025 | 2025-08-12 | -0.16 | -0.10 | -60.0% | — | — | — |
| Q1 2025 | 2025-05-14 | -0.18 | -0.24 | +25.0% | — | — | — |
| Q4 2024 | 2025-03-26 | 0.08 | -0.35 | +122.9% | — | — | — |
| Q2 2024 | 2024-08-12 | -0.17 | -0.14 | -21.4% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.